Page last updated: 2024-08-24

atorvastatin and Cholestasis

atorvastatin has been researched along with Cholestasis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
García Pajares, F; Maroto-Martín, C; Molina Terrón, PM1
Carvalho, D; Rodrigues, E; Saavedra, A1
Claudel, T; Fauler, G; März, W; Putz-Bankuti, C; Scharnagl, H; Sourij, H; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M; Wascher, TC; Winkler, K1
Alvaro, D; Attili, AF; Bragazzi, MC; Callea, F; Giubilo, F; Merli, M1
Baz, A; Clofent, J; de Castro, ML; de Luaces, C; Hermo, JA; Pérez, R1
Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M1
Mandó, OG; Ridruejo, E1

Trials

1 trial(s) available for atorvastatin and Cholestasis

ArticleYear
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
    Atherosclerosis, 2010, Volume: 209, Issue:1

    Topics: Atorvastatin; Blood Vessels; Cardiovascular Diseases; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles

2010

Other Studies

6 other study(ies) available for atorvastatin and Cholestasis

ArticleYear
Atorvastatin-induced acute cholestatic hepatitis.
    Medicina clinica, 2022, 12-09, Volume: 159, Issue:11

    Topics: Acute Disease; Atorvastatin; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatitis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors

2022
[Dyslipidemia Secondary to Hypothyroidism and Cholestasis].
    Acta medica portuguesa, 2020, Mar-02, Volume: 33, Issue:3

    Topics: Atorvastatin; Autoimmune Diseases; Cholestasis; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Liver Cirrhosis, Biliary; Middle Aged; Obesity; Thyroxine; Withholding Treatment

2020
Atorvastatin-induced prolonged cholestasis with bile duct damage.
    Clinical drug investigation, 2010, Volume: 30, Issue:3

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Dyslipidemias; Heptanoic Acids; Humans; Male; Pyrroles; Ursodeoxycholic Acid

2010
[Acute cholestatic hepatitis after atorvastatin reintroduction].
    Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:1

    Topics: Acute Disease; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Cholestasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles

2006
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:3

    Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid

2007
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.
    Journal of hepatology, 2002, Volume: 37, Issue:1

    Topics: Acute Disease; Aged; Atorvastatin; Cholestasis; Hepatitis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles

2002